info@clinicone.com.np

+977 01-5009233/ 9863393960

Home » HPV – Humanpapilloma Virus Vaccine

HPV – Humanpapilloma Virus Vaccine

Get HPV Vaccine in Kathmandu Nepal

Do you need HPV Vaccine in Kathmandu Nepal?

Clinic One offers this vaccine in a friendly clean convenient environment.

Name of the medicinal product: Human papillomavirus Vaccine rDNA Ph. Eur

Therapeutic Indications

Females from 9 – 45 years of age for the prevention of cervical cancer by protecting against incident and persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC – US) and cervical intraepithelial neoplasia (CIN), CIN 1 and precancerous lesions (CIN 2 and CIN 3) caused by human papilloma virus type 16 and 18.

 

Method of administration

It depends on the age of the subjects

A third dose should always be administered, if the second vaccine dose is received before the 5th month after the first dose.

If the flexibility in the vaccination schedule is necessary, the second dose can be administered between 1 month and 2, 5 months after the first dose and the third dose between 5 to 12 months after the first dose.

The need for the booster dose has not been established.

Pediatric Population

It is not recommended for use in girls below 9 years of age due to lack of data on safety and immunogenicity at this age- group.

Method of administration

Intramuscular injection in the deltoid region.

Contraindications

  • Hypersensitivity to active substances
  • Pregnancy
  • Lactation

Administration of CERVARIX should be postponed in patients suffering from an acute severe febrile illness. However, the presence of a minor infection such as cold is not a contraindication for immunization.

 

Adverse Reactions

Very common:  Pain at the injection site, Headache, rash, Myalgia, Nausea, vomiting

Common: Fever

Other: Arthralgia

Special warnings and precautions for use

  • The vaccination of an individual woman should take into account her risk for previous HPV exposure and her likely benefit from vaccination.
  • It will only protect against diseases that are caused by HPV types 16 and 18 and to some extent against diseases caused by certain other oncogenic related HPV types. Therefore, appropriate precautions against STD’s should continue to be used.
  • It is for prophylactic use only and has no effect on active HPV infection or established clinical disease.

Back to Vaccination Page.